28103582|t|AMPK - autophagy inhibition sensitizes icaritin - induced anti-colorectal cancer cell activity
28103582|a|The current research studied the potential effect of autophagy on icaritin - induced anti-colorectal cancer (CRC) cell activity. Treatment of icaritin in both primary and established (HT-29) CRC cells induced feedback activation of autophagy, evidenced by p62 degradation, Beclin-1 and autophagy-related gene-5 (ATG-5) upregulation, as well as light chain 3B (LC3B)- GFP puncta formation. Pharmacological inhibiting of autophagy dramatically potentiated icaritin - induced CRC cell death and apoptosis. Meanwhile, shRNA -mediated knockdown of Beclin-1 or ATG-5 also sensitized icaritin - induced CRC cell death and apoptosis. Icaritin activated AMP-activated protein kinase (AMPK) signaling in CRC cells, functioning as the upstream signaling for autophagy activation. shRNA / siRNA -mediated knockdown of AMPKα1 inhibited icaritin - induced autophagy activation, but exacerbated CRC cell death. On the other hand, the AMPK activator compound 13 (C13) or the autophagy activator MHY1485 attenuated icaritin - induced cytotoxicity. In nude mice, icaritin (oral administration)- induced HT-29 tumor growth inhibition was potentiated when combined with AMPKα1 shRNA knockdown in tumors. We conclude that feedback activation of AMPK - autophagy pathway could be a primary resistance factor of icaritin.
28103582	0	4	AMPK	T116,T126	C2350345
28103582	7	16	autophagy	T043	C0004391
28103582	17	27	inhibition	T052	C3463820
28103582	39	47	icaritin	T109,T123	C1567768
28103582	50	57	induced	T169	C0205263
28103582	58	80	anti-colorectal cancer	T033	C0243095
28103582	81	94	cell activity	T043	C0007613
28103582	99	106	current	T079	C0521116
28103582	107	115	research	T062	C0035168
28103582	128	144	potential effect	T080	C1280500
28103582	148	157	autophagy	T043	C0004391
28103582	161	169	icaritin	T109,T123	C1567768
28103582	172	179	induced	T169	C0205263
28103582	180	202	anti-colorectal cancer	T033	C0243095
28103582	204	207	CRC	T191	C1527249
28103582	209	222	cell activity	T043	C0007613
28103582	224	233	Treatment	T169	C1522326
28103582	237	245	icaritin	T109,T123	C1567768
28103582	254	261	primary	T080	C0205225
28103582	266	277	established	T080	C0443211
28103582	279	284	HT-29	T025	C0282639
28103582	286	289	CRC	T191	C1527249
28103582	290	295	cells	T025	C0007634
28103582	296	303	induced	T169	C0205263
28103582	304	323	feedback activation	T052	C1879547
28103582	327	336	autophagy	T043	C0004391
28103582	351	354	p62	T028	C1420393
28103582	355	366	degradation	T044	C0314674
28103582	368	376	Beclin-1	T028	C1412785
28103582	381	405	autophagy-related gene-5	T028	C1825497
28103582	407	412	ATG-5	T028	C1825497
28103582	414	426	upregulation	T044	C0041904
28103582	439	453	light chain 3B	T116	C1311384
28103582	455	459	LC3B	T116	C1311384
28103582	462	465	GFP	T116,T130	C0120285
28103582	473	482	formation	T169	C1522492
28103582	484	499	Pharmacological	T169	C0205464
28103582	500	510	inhibiting	T052	C3463820
28103582	514	523	autophagy	T043	C0004391
28103582	549	557	icaritin	T109,T123	C1567768
28103582	560	567	induced	T169	C0205263
28103582	568	571	CRC	T191	C1527249
28103582	572	582	cell death	T043	C0007587
28103582	587	596	apoptosis	T043	C0162638
28103582	609	614	shRNA	T114	C2930586
28103582	625	634	knockdown	T063	C2350567
28103582	638	646	Beclin-1	T028	C1412785
28103582	650	655	ATG-5	T028	C1825497
28103582	672	680	icaritin	T109,T123	C1567768
28103582	683	690	induced	T169	C0205263
28103582	691	694	CRC	T191	C1527249
28103582	695	705	cell death	T043	C0007587
28103582	710	719	apoptosis	T043	C0162638
28103582	721	729	Icaritin	T109,T123	C1567768
28103582	730	739	activated	T052	C1879547
28103582	740	768	AMP-activated protein kinase	T116,T126	C2350345
28103582	770	774	AMPK	T116,T126	C2350345
28103582	776	785	signaling	T043	C0037083
28103582	789	792	CRC	T191	C1527249
28103582	793	798	cells	T025	C0007634
28103582	800	811	functioning	T169	C0542341
28103582	828	837	signaling	T043	C0037083
28103582	842	851	autophagy	T043	C0004391
28103582	852	862	activation	T052	C1879547
28103582	864	869	shRNA	T114	C2930586
28103582	872	877	siRNA	T114,T123	C1099354
28103582	888	897	knockdown	T063	C2350567
28103582	901	907	AMPKα1	T028	C1418897
28103582	908	917	inhibited	T080	C0311403
28103582	918	926	icaritin	T109,T123	C1567768
28103582	929	936	induced	T169	C0205263
28103582	937	946	autophagy	T043	C0004391
28103582	947	957	activation	T052	C1879547
28103582	963	974	exacerbated	T080	C1444749
28103582	975	978	CRC	T191	C1527249
28103582	979	989	cell death	T043	C0007587
28103582	1014	1018	AMPK	T116,T126	C2350345
28103582	1029	1040	compound 13	T121	C1254351
28103582	1042	1045	C13	T121	C1254351
28103582	1054	1063	autophagy	T043	C0004391
28103582	1074	1081	MHY1485	T109,T121	C3661263
28103582	1082	1092	attenuated	T052	C0599946
28103582	1093	1101	icaritin	T109,T123	C1567768
28103582	1104	1111	induced	T169	C0205263
28103582	1112	1124	cytotoxicity	T049	C0596402
28103582	1129	1138	nude mice	T015	C0025932
28103582	1140	1148	icaritin	T109,T123	C1567768
28103582	1150	1169	oral administration	T061	C0001563
28103582	1172	1179	induced	T169	C0205263
28103582	1180	1185	HT-29	T025	C0282639
28103582	1186	1198	tumor growth	T191	C0598934
28103582	1199	1209	inhibition	T052	C3463820
28103582	1245	1251	AMPKα1	T028	C1418897
28103582	1252	1257	shRNA	T114	C2930586
28103582	1258	1267	knockdown	T063	C2350567
28103582	1271	1277	tumors	T191	C0027651
28103582	1296	1315	feedback activation	T052	C1879547
28103582	1319	1323	AMPK	T116,T126	C2350345
28103582	1326	1335	autophagy	T043	C0004391
28103582	1336	1343	pathway	T044	C0037080
28103582	1363	1373	resistance	T169	C4281815
28103582	1374	1380	factor	T169	C1521761
28103582	1384	1392	icaritin	T109,T123	C1567768